Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ed Kheder"'
Autor:
Anas Alshawa, Jing Gong, Valerie Marcott, Rabia Khan, Valentine Boving, Lakeshia Brown, Jeff Beno, Ed Kheder, Siqing Fu
Publikováno v:
Global Journal on Quality and Safety in Healthcare, Pp 5-10 (2019)
Background: The use of oral antineoplastic agents has increased in cancer medicine. However, the convenience of oral medication carries the risk of nonadherence and dosing errors, which could jeopardize therapeutic benefits and patient safety. This i
Externí odkaz:
https://doaj.org/article/4e996b5468614e128dd41d069b5da096
Autor:
Joanna-Grace M. Manzano, Mayoora Muthu, Ed Kheder, Alyssa Mohammed, Josiah Halm, Kodwo Dickson, Noman Ali, Cerena Leung, Kwame Koom-Dadzie, David Rubio, Orhue Odaro, Michelle Sibille, Mikel Etchegaray, Kaycee Wilson, Heather Lin, Marina George
Publikováno v:
Supportive Care in Cancer. 30:7783-7788
Several studies have confirmed increased mortality among patients with both COVID-19 and cancer. It remains important to continue to report observations of morbidity and mortality from COVID-19 in this vulnerable population. The purpose of this study
Autor:
Patricia A Brock, Cielito C. Reyes-Gibby, Maria T. Cruz-Carreras, Eva Rajha, Susan Gaeta, Adianes Feliciano, Demis N. Lipe, Ed Kheder, Jenny Ren, Jomol Thomas, Ahmed Elsayem, Elisabet E. Manasanch
Publikováno v:
Annals of Palliative Medicine. 10:1763-1771
Background Cancer patients are vulnerable to the coronavirus disease (COVID-19) given their compromised immune system. The purpose of this study was to describe the presenting symptoms, inpatient stay trajectory, and survival outcomes, for cancer pat
Autor:
Siqing Fu, Rabia Khan, Lakeshia Brown, Anas Alshawa, Jing Gong, Jeff Beno, Ed Kheder, Valerie D. Marcott, Valentine G. Boving
Publikováno v:
Global Journal on Quality and Safety in Healthcare. 2:5-10
Background: The use of oral antineoplastic agents has increased in cancer medicine. However, the convenience of oral medication carries the risk of nonadherence and dosing errors, which could jeopardize therapeutic benefits and patient safety. This i
Autor:
David S. Hong, Ed Kheder
Publikováno v:
Clinical Cancer Research. 24:5807-5814
The oncogenesis-promoting role of chromosomal rearrangements for several hematologic and solid malignancies is well recognized. However, identifying targetable, actionable, and druggable chromosomal rearrangements remains a challenge. Targeting gene
Autor:
Hadeel Neamat Sahar, Kwame Koom-Dadzie, Kodwo Dickson, Jeffrey Aldrich, Cesar Simbaqueba, Maria Franco-Vega, Christine B. Peterson, Alyssa Mohammed, Ed Kheder, Michelle Sibille, Joanna-Grace Manzano, Mayoora Muthu, Mahran Shoukier, Norman Brito-Dellan, Maggie Lu
Publikováno v:
Journal of Clinical Oncology. 39:e21054-e21054
e21054 Background: Immune checkpoint inhibitors (ICI) have gained success in the treatment of multiple malignancies including lung cancer. However, immune-related adverse events (irAE) are common with pneumonitis being one of the most fatal having a
Autor:
Joanna-Grace Manzano, Dereddi Raja Reddy, Nisha Rathi, Cristina Gutierrez, Nirmala Manjappachar, Robert Wegner, Cerena Leung, Ed Kheder, John Cuenca, Mayoora Muthu, Kristen Price, John Crommett, Joseph L. Nates
Publikováno v:
Critical Care Medicine. 49:59-59
INTRODUCTION: Several reports have associated COVID-19 and cancer patients with poor outcomes We describe outcomes of COVID-19 cancer patients who required ICU level care METHODS: A retrospective cohort of cancer patients with COVID-19 admitted to a
Publikováno v:
Journal of Investigative Medicine
As evidence regarding the impact of preceding medications on resuscitation outcomes has been inconsistent, this study aimed to analyze the association between preceding medications and resuscitation outcomes in patients experiencing out-of-hospital c
Autor:
Kenneth R. Hess, Funda Meric-Bernstam, Vivek Subbiah, Maria Angelica Cortez, Siqing Fu, Aung Naing, Jordi Rodon Ahnert, Timothy A. Yap, Daniel D. Karp, Shubham Pant, Sarina Anne Piha-Paul, Ed Kheder, James W. Welsh, Filip Janku, Hussein Abdul-Hassan Tawbi, Yan Xing, David S. Hong
Publikováno v:
Journal of Clinical Oncology. 36:12052-12052
12052Background: The regulation of Programmed cell death ligand-1 (PD-L1) expression remains poorly understood. Preclinical data suggest that TP53, via microRNA-34, regulates PD-L1 expression in lu...
Autor:
Keyur P. Patel, Yan Xing, Vivek Subbiah, Ed Kheder, Filip Janku, Le Huang, Kenneth R. Hess, Funda Meric-Bernstam, Kenna Rael Shaw
Publikováno v:
Journal of Clinical Oncology. 36:12100-12100
12100Background: BRAF mutations that occur outside of codon 600, non-V600 BRAF (non-V600BRAF), have been detected in various types of tumors. Prevalence, and prognostic impact remain underestimated...